moricizine

DRUG3 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)

Conditions

ArrhythmiaAtrial FibrillationCardiovascular DiseasesCoronary DiseaseDeath, Sudden, CardiacHeart ArrestHeart DiseasesMyocardial Infarction

Phase 2

Cardiac Arrhythmia Pilot Study (CAPS)

CompletedNCT00000504

National Heart, Lung, and Blood Institute (NHLBI)Arrhythmia, Cardiovascular Diseases, Heart Diseases +1

Start: 1982-09-30End: 1985-09-30Updated: 2012-04-27

Phase 3

Cardiac Arrhythmia Suppression Trial (CAST)

CompletedNCT00000526

National Heart, Lung, and Blood Institute (NHLBI)Cardiovascular Diseases, Coronary Disease, Death, Sudden, Cardiac +5

Start: 1986-08-31End: 1998-03-31Updated: 2016-05-06

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

CompletedNCT00000556

National Heart, Lung, and Blood Institute (NHLBI)Arrhythmia, Atrial Fibrillation, Cardiovascular Diseases +1

Start: 1995-03-31End: 2002-09-30Updated: 2016-03-25

Related Papers

Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation

Hypertension2017-10-0431 citations